Peptidomimetic Growth Hormone Secretagogues. Design Considerations and Therapeutic Potential
- 17 July 1998
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (17) , 3103-3127
- https://doi.org/10.1021/jm970342o
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beaglesJournal of Endocrinology, 1997
- Structure-function analysis of the cloned opiate receptors: peptide and small molecule interactionsChemistry & Biology, 1996
- Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in ratsLife Sciences, 1995
- The Growth Hormone Secretagogue, L-692,429, Induces Phosphatidylinositol Hydrolysis and Hormone Secretion by Human Pituitary TumorsBiochemical and Biophysical Research Communications, 1995
- GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult ratsLife Sciences, 1994
- Reconstitution of functional muscarinic receptors by co‐expression of amino‐ and carboxyl‐terminal receptor fragmentsFEBS Letters, 1993
- GH Releasing Peptides - Structure and KineticsJournal of Pediatric Endocrinology and Metabolism, 1993
- The hippocampus—what does it do?Behavioral and Neural Biology, 1992
- Growth-hormone receptor clonedNature, 1987
- Growth hormone-releasing factor stimulates adenylate cyclase activity in the anterior pituitary glandLife Sciences, 1983